116 related articles for article (PubMed ID: 10071240)
1. Histopathological and biochemical studies on pancreatic fibrosis in WBN/Kob rats.
Kakinuma C; Suda K; Shibutani Y
Virchows Arch; 1999 Jan; 434(1):83-9. PubMed ID: 10071240
[TBL] [Abstract][Full Text] [Related]
2. Role of fibrosis-related genes and pancreatic duct obstruction in rat pancreatitis models: implications for chronic pancreatitis.
Miyauchi M; Suda K; Kuwayama C; Abe H; Kakinuma C
Histol Histopathol; 2007 Oct; 22(10):1119-27. PubMed ID: 17616939
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase-derived oxygen radicals play significant roles in the development of chronic pancreatitis in WBN/Kob rats.
Zeki S; Miura S; Suzuki H; Watanabe N; Adachi M; Yokoyama H; Horie Y; Saito H; Kato S; Ishii H
J Gastroenterol Hepatol; 2002 May; 17(5):606-16. PubMed ID: 12084036
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.
Kuno A; Yamada T; Masuda K; Ogawa K; Sogawa M; Nakamura S; Nakazawa T; Ohara H; Nomura T; Joh T; Shirai T; Itoh M
Gastroenterology; 2003 Apr; 124(4):1010-9. PubMed ID: 12671898
[TBL] [Abstract][Full Text] [Related]
5. Diabetic strain (WBN/Kob) of rat characterized by endocrine-exocrine pancreatic impairment due to distinct fibrosis.
Mori Y; Yokoyama J; Nishimura M; Kurata H; Miura J; Ikeda Y
Pancreas; 1990 Jul; 5(4):452-9. PubMed ID: 1696384
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic effect of the herbal medicine Saiko-keishi-to (TJ-10) on chronic pancreatitis in the WBN/Kob rat.
Su SB; Motoo Y; Xie MJ; Taga H; Sawabu N
Pancreas; 2001 Jan; 22(1):8-17. PubMed ID: 11138977
[TBL] [Abstract][Full Text] [Related]
7. Involvement of lipid peroxidation in spontaneous pancreatitis in WBN/Kob rats.
Furukawa F; Nishikawa A; Kasahara K; Miyauchi M; Nakamura H; Son HY; Uchida K; Hirose M
Pancreas; 2001 May; 22(4):427-30. PubMed ID: 11345145
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation.
Hisada S; Shimizu K; Shiratori K; Kobayashi M
Rocz Akad Med Bialymst; 2005; 50():142-7. PubMed ID: 16358954
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma in spontaneous chronic pancreatitis in the WBN/Kob rat.
Xie MJ; Motoo Y; Su SB; Sawabu N
Pancreas; 2001 May; 22(4):400-8. PubMed ID: 11345142
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor-beta in spontaneous chronic pancreatitis in the WBN/Kob rat.
Su SB; Motoo Y; Xie MJ; Miyazono K; Sawabu N
Dig Dis Sci; 2000 Jan; 45(1):151-9. PubMed ID: 10695628
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids.
Hashimoto T; Yamada T; Yokoi T; Sano H; Ando H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M
Pancreas; 2000 Oct; 21(3):296-304. PubMed ID: 11039475
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis.
Sugiyama M; Kobori O; Atomi Y; Wada N; Kuroda A; Muto T
Pancreas; 1996 Jul; 13(1):71-9. PubMed ID: 8783337
[TBL] [Abstract][Full Text] [Related]
13. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats.
Yamada T; Kuno A; Masuda K; Ogawa K; Sogawa M; Nakamura S; Ando T; Sano H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M
J Pharmacol Exp Ther; 2003 Oct; 307(1):17-23. PubMed ID: 12944495
[TBL] [Abstract][Full Text] [Related]
14. Increased intestinal phospholipase A(2) activity catalyzed by phospholipase B/lipase in WBN/Kob rats with pancreatic insufficiency.
Tchoua U; Ito M; Okamoto M; Tojo H
Biochim Biophys Acta; 2000 Sep; 1487(2-3):255-67. PubMed ID: 11018477
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis.
Yokota T; Denham W; Murayama K; Pelham C; Joehl R; Bell RH
J Surg Res; 2002 May; 104(2):106-11. PubMed ID: 12020128
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Yamada T; Kuno A; Ogawa K; Tang M; Masuda K; Nakamura S; Ando T; Okamoto T; Ohara H; Nomura T; Joh T; Shirai T; Itoh M
J Pharmacol Exp Ther; 2005 Apr; 313(1):36-45. PubMed ID: 15608084
[TBL] [Abstract][Full Text] [Related]
17. Reduced reactivity of pancreatic exocrine secretion in response to gastrointestinal hormone in WBN/Kob rats.
Arai I; Komatsu Y; Sasaki K; Taguchi S
J Gastroenterol; 1998 Apr; 33(2):247-53. PubMed ID: 9605957
[TBL] [Abstract][Full Text] [Related]
18. The influence of dietary restriction on the development of diabetes and pancreatitis in female WBN/Kob-fatty rats.
Akimoto T; Terada M; Shimizu A; Sawai N; Ozawa H
Exp Anim; 2010; 59(5):623-30. PubMed ID: 21030790
[TBL] [Abstract][Full Text] [Related]
19. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.
Reding T; Bimmler D; Perren A; Sun LK; Fortunato F; Storni F; Graf R
Gut; 2006 Aug; 55(8):1165-73. PubMed ID: 16322109
[TBL] [Abstract][Full Text] [Related]
20. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis.
Ohashi K; Kim JH; Hara H; Aso R; Akimoto T; Nakama K
Int J Pancreatol; 1990 Jun; 6(4):231-47. PubMed ID: 1698893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
